Insmed Incorporated (INSM)

Insmed Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	381.03	363.71	305.21	245.36	188.46	164.41
Revenue Growth (YoY)	20.77%	19.17%	24.39%	30.19%	14.63%	20.48%
Cost of Revenue	89.56	85.74	65.57	55.13	44.15	39.87
Gross Profit	291.47	277.97	239.64	190.23	144.31	124.54
Selling, General & Admin	515.56	461.12	344.5	265.78	233.67	203.61
Research & Development	629.86	598.37	571.01	397.52	272.74	181.16
Operating Expenses	1,150	1,065	920.56	668.36	511.47	389.77
Operating Income	-859.01	-786.57	-680.93	-478.12	-367.16	-265.23
Interest Expense	-88.04	-85.15	-81.37	-27.97	-40.47	-29.56
Interest & Investment Income	58.43	53.31	42.13	11.08	0.17	1.7
Other Non Operating Income (Expenses)	1.26	0.03	1.86	-5.94	-3.33	0.41
EBT Excluding Unusual Items	-887.35	-818.38	-718.32	-500.95	-410.79	-292.69
Merger & Restructuring Charges	-	-	-	-	-0.6	-
Other Unusual Items	-121.88	-91.68	-28.7	20.8	-25.02	-
Pretax Income	-1,009	-910.07	-747.01	-480.15	-436.41	-292.69
Income Tax Expense	4.03	3.71	2.56	1.38	-1.76	1.4
Net Income	-1,013	-913.77	-749.57	-481.53	-434.65	-294.09
Net Income to Common	-1,013	-913.77	-749.57	-481.53	-434.65	-294.09
Shares Outstanding (Basic)	172	164	140	123	112	98
Shares Outstanding (Diluted)	172	164	140	123	112	98
Shares Change (YoY)	20.00%	16.81%	14.14%	9.74%	14.86%	15.43%
EPS (Basic)	-5.89	-5.57	-5.34	-3.91	-3.88	-3.01
EPS (Diluted)	-5.89	-5.57	-5.34	-3.91	-3.88	-3.01
Free Cash Flow	-789.25	-705.81	-549.54	-410.32	-370.59	-225.59
Free Cash Flow Per Share	-4.58	-4.30	-3.91	-3.33	-3.31	-2.31
Gross Margin	76.50%	76.43%	78.52%	77.53%	76.57%	75.75%
Operating Margin	-225.44%	-216.27%	-223.10%	-194.87%	-194.82%	-161.32%
Profit Margin	-265.93%	-251.24%	-245.59%	-196.26%	-230.63%	-178.87%
Free Cash Flow Margin	-207.14%	-194.06%	-180.05%	-167.23%	-196.64%	-137.21%
EBITDA	-849.84	-777.7	-672.49	-465.83	-351.9	-250
EBITDA Margin	-223.04%	-213.82%	-220.34%	-189.86%	-186.72%	-152.06%
D&A For EBITDA	9.17	8.88	8.44	12.29	15.26	15.23
EBIT	-859.01	-786.57	-680.93	-478.12	-367.16	-265.23
EBIT Margin	-225.44%	-216.27%	-223.10%	-194.87%	-194.82%	-161.32%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q